Importation

“Canada cannot act as a drugstore for the United States,” says academic

In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”

[...]

Drug Importation threatens people with chronic illnesses, says advocate.

This editorial by Guy Anthony was published in the Orlando Sentinel on June 12, 2019. Anthony, President and CEO of Black, Gifted & Whole, a nonprofit focused on issues surrounding black, queer men, warns that drug importation will open up “a market for dangerous, counterfeit drugs” that will make it harder for people to live with HIV and other complex illnesses.

[...]

PSM responds to AMA resolution #129 (A-19) on Mexico drug importation – June 9, 2019

Recently the Partnership for Safe Medicines learned of and responded to a proposed resolution for the American Medical Association’s House of Delegates regarding importation of medicine from the Mexican drug supply and PSM’s response. Resolution a19-r129 Benefits of Importation of Pharmaceuticals PSM Response to AMA Resolution_ 129 (importing prescription drugs from Mexico)

[...]

Florida Agency for Health Care Administration releases Request for Information for Canadian Prescription Drug Importation Program

Florida’s Agency for Health Care Administration released a Request for Information for a Canadian Prescription Drug Importation Program. It specifically asked “The Agency is seeking information from entities with direct experience in coordinating all aspects of Canadian prescription drug importation. ” Responses are due June 25, 2019. Read the RFI

[...]